Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys

Fuwa M., Toris C.B., Fan S., Taniguchi T., Ichikawa M., Odani-Kawabata N., Iwamura R., Yoneda K., Matsugi T., Shams N.K., Zhang J.-Z.

2018
Journal of Ocular Pharmacology and Therapeutics

View publication

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

RandD Division, Santen Pharmaceutical Co. Ltd., 8916-16 Takayama-cho, Ikoma-shi Nara, 630-0101, Japan; Department of Ophthalmology, Nebraska Medical Center, University of Nebraska Medical Center, Omaha, NE, United States; Department of Ophthalmology, Case Western Reserve University, Cleveland, OH, United States; RandD Division, Santen Pharmaceutical Co. Ltd., Osaka, Japan; Pharmaceuticals Research Laboratory, Pharmaceutical Division, Ube Industries, Ltd., Yamaguchi, Japan; RandD Division, Santen Inc., Emeryville, CA, United States

Related Publications

Benefit of omidenepag isopropyl ophthalmic solution in treatment persistence in Japanese patients with glaucoma

Kashiwagi K., Nakano T., Nakazawa T., Fuwa M., Otsuka N., Shii D., Miyahara R.

Posterior Ciliary Artery Contraction by Bradykinin Receptor Subtypes and Implications for Retinal Blood Flow Dysfunction

Sharif NA, Ohia SE, Kulkarni-Chitnis M, Okolie A, Chaudhry SD, Njie-Mbye YF

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A 3-Year Prospective Study

Akagi T, Fukuchi T, Higashide T, Udagawa S, Ohkubo S, Sugiyama K, Tanihara H, Araie M, Tomita G, Matsumoto C, Tomidokoro A, Hangai M, Kawata H, Inai M, Tanaka Y; SVF Prospector Study Group.

View all Glaucoma publications